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Abstract
Background: The usual method of assessing the variability of a measure such as the ankle brachial
index (ABI) as a function of different observer groups is to obtain repeated measurements. Because
the number of possible observer-subject combinations is impractically large, only a few small
studies on inter- and intraobserver variability of ABI measures have been carried out to date. The
present study proposes a new and efficient study design. This paper describes the study
methodology.
Methods: Using a partially balanced incomplete block design, six angiologists, six primary-care
physicians and six trained medical office assistants performed two ABI measurements each on six
individuals from a group of 36 unselected subjects aged 65–70 years. Each test subject is measured
by one observer from each of the three observer groups, and each observer measures exactly six
of the 36 subjects in the group. Each possible combination of two observers occurs exactly once
per patient and is not repeated on a second subject. The study involved four groups of 36 subjects
(144), plus standbys.
Results: The 192 volunteers present at the study day were similar in terms of demographic
characteristics and vascular risk factors: mean age 68.6 ± 1.7; mean BMI 29.1 ± 4.6; mean waist-hip
ratio 0.92 ± 0.09; active smokers 12%; hypertension 60.9%; hypercholesterolemia 53.4%; diabetic
17.2%. A complete set of ABI measurements (three observers performing two Doppler
measurements each) was obtained from 108 subjects. From all other subjects at least one ABI
measurement was obtained. The mean ABI was 1.08 (± 0.13), 15 (7.9%) volunteers had an ABI <0.9,
and none had an ABI >1.4, i.e. a ratio that may be associated with increased stiffening of the arterial
walls.
Conclusion: This is the first large-scale study investigating the components of variability and thus
reliability in ABI measurements. The advantage of the new study design introduced here is that only
one sixth of the number of theoretically possible measurements is required to obtain information
about measurement errors. Bland-Altman plots show that there are only small differences and no
systematic bias between the observers from three occupational groups with different training
backgrounds.
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Background
Coronary heart disease and stroke as manifestations of
atherosclerosis are among the leading causes of death.
Consequently, there has been an intensive search for
measures of atherosclerosis burden that would indicate
the cardiovascular and overall risk of the individual
patient [1]. An early indicator of possible generalized
atherosclerosis is peripheral arterial disease (PAD), which
refers to the manifestation of atherosclerosis below the
aortal bifurcation [2,3].
An early and reproducible diagnosis of PAD is important
for identifying high-risk patients as early as possible. Only
a minority of patients exhibit the symptoms of intermit-
tent claudication. Data from the literature suggest that for
every patient with intermittent claudication, there are at
least three with asymptomatic PAD [4].
The introduction of Doppler sonography has made it pos-
sible for general physicians to diagnose asymptomatic
PAD by determining the ankle-brachial index (ABI),
which represents the ratio of ankle to brachial systolic
blood pressure (SBP) [5,6]. ABI values below 0.9 are con-
sidered pathological (presence of PAD) [7,8]. Compared
to angiography, the sensitivity of a low ABI for leg artery
stenosis of ≥ 50% is about 90%, and the specificity is
about 98% [9]. In a recent systematic review, the specifi-
city of low ABI to predict future cardiovascular outcomes
was high (e.g. 88% for cardiovascular mortality), but the
sensitivity was low (41%) [10].
To establish ABI determination as a screening procedure
for asymptomatic PAD, the interobserver variability
(same subject, different observers) and intraobserver vari-
ability (same subject, same observer) of ABI measures
must be known. Of particular interest is how these two
types of variability differ depending on the observer's level
of specialization. The present study therefore set out to
determine inter- and intraobserver variability of ABI
measurements by three groups of observers (angiologists,
general physicians and medical office assistants) and with
a sufficiently large number of randomly selected subjects,
age 65 to 70, free of serious disease and without sympto-
matic PAD (the target group of ABI screening measure-
ments). In order to avoid having to make very large
numbers of measurements (impractical for both subjects
and observers), a study design was developed that pro-
vides the necessary information with one sixth the
number of Doppler measures that would otherwise have
to be performed. The paper deals with the study method-
ology.
Methods
Study population
Volunteers were eligible for inclusion in the study if they
were members of a public health insurance plan (in this
case BKK Hoechst), between the ages of 65 and 70, resi-
dent in Frankfurt-Hoechst, ambulatory without wheel-
chair or walking aids, able to understand the study and
able to provide written informed consent. Exclusion crite-
ria were: need for nursing care of any kind, serious disease
such as cancer, any amputation of upper or lower extrem-
ities, and a history of stroke with hemiplegia. Figure 1
shows the study flow. A total of 1062 subjects meeting the
inclusion criteria received a letter from the BKK Hoechst
insurance plan inviting them to participate in the study.
A total of 382 people (36.0%) responded to the study
center in Bochum, of whom 310 were interested in partic-
ipating and 270 signed the statement of informed con-
sent. To ensure that at least 144 subjects would be
available for the ABI measurements on the day of the
study (four groups of 36), the first 100 men and the first
100 women to respond to the invitation were asked to
attend. As a result there were 14 more participants per
group than the minimum of 36 required (stand-by). The
four groups were asked to arrive at 1.5- to 2.5-hour inter-
vals. Another 20 subjects whose data were not to be
Patient disposition and study flow Figure 1
Patient disposition and study flow.
1062 members of BKK Hoechst
insurance plan
receive invitation letter
382 subjects (36.0%)
reported to the study centre
in Bochum
270 subjects
sent written confirmation
100 women and 100 men
selected for study participation
192 participated (96%)
Study day
144 subjects for duplicate ABI measurements
Group 1 (8 a.m.): 36 participants
Group 2 (9:30 a.m.): 36 participants
Group 3 (12 a.m.): 36 participants
Group 4 (1:30 p.m.): 36 participants
48 stand-by subjects (only one ABI measurement)
Analysed patients
117 subjects with 6 ABI measurements, of them
108 in the main analysis
17 subjects with 5 ABI measurements
10 subjects with 3 or 4 ABI measurements
20 selected for pilot study
18 participated (90%)
No ABI measurement
on 3 subjects:
1 withdrew consent
2 for technical reasonsBMC Cardiovascular Disorders 2006, 6:33 http://www.biomedcentral.com/1471-2261/6/33
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included in the analysis of results were asked to partici-
pate in a "dress rehearsal" one day before the actual study
day. The study was conducted in accordance with the Hel-
sinki Declaration and the Guideline for Good Epidemio-
logical Practice (GEP) issued by the German Working
Group on Epidemiology [11]. The study was approved by
the ethics committee of the Ruhr-University of Bochum.
Observers
The duplicate ABI measurements were performed by six
angiologists, six general physicians (GPs) and six medical
office assistants with special training in Doppler measure-
ments (MAs). The angiologists (internists with a speciali-
zation in angiology) were selected from the "centers of
excellence" (coordinating and training centers) of the Ger-
man Epidemiological Trial on Ankle-Brachial Index (get-
ABI) [8,12]. The GPs were also investigators in getABI and
were chosen by the angiologists. The MAs were employees
of the angiologists and specialized in ABI measurements.
The basic physical examinations were performed by sepa-
rate observers (three angiologists and three GPs) who
were not involved in performing the duplicate ABI meas-
urements. These extra angiologists/GPs also performed a
single ABI measurement on the stand-by subjects.
Study design
On the study day (December 12, 2005), all volunteers first
underwent a physical examination by an angiologist or
GP. This basic examination covered weight and height for
calculating BMI (seca 703 electronic column scale with
built-in seca 220 height measuring rod, seca GmbH Ham-
burg, Germany), waist and hip circumference for calculat-
ing waist-hip ratio, and patient history regarding vascular-
related comorbidities (Table 1), obtained in a standard-
ized manner and recorded on case report forms.
The first 36 consecutive subjects in each group were called
up for repeat ABI measurements, and the remaining 14
subjects were registered as stand-bys. This procedure was
followed for four groups. Stand-bys underwent only a sin-
gle ABI measurement (not used for study purposes).
For the ABI repeat measurements, each subject saw exactly
one observer from each of the three observer groups (angi-
ologists, GPs and MAs), and each observer measured six of
the 36 subjects in a group (Table 2). Each possible two-
way combination of angiologist, GP and MA drawn from
the six representatives of the three occupations occurred
exactly once and was not repeated on a second subject in
the same group, as this was a condition for being able to
calculate the inter- and intraobserver variability of the ABI
measures with only three observers per subject and only
six subjects per observer. Thanks to this partially balanced
incomplete block design, it was not necessary for all 18
observers to perform two measurements on each of the
4*36 subjects (the usual procedure for duplicate measure-
ments), which would have resulted in a total of 5184 ABI
measurements, but only on 4*6 subjects, which resulted
in 864 measurements (16.7% of 5184), sufficient to pro-
vide the same information with the desired precision.
Outcome measures
The primary purpose of the study was the assessment of
three sources of variability, namely the true differences in
ABI between subjects, the measurement error arising from
duplicate measurements of the same subject by the same
observer (intraobserver variability), and the additional
error arising from measurements by different observers
(interobserver variability). Secondary outcome measures
were body mass index, waist-hip ratio, and risk factors for
atherosclerotic complications (smoking, hypertension,
lipid disorders, diabetes mellitus, symptomatic PAD).
Doppler measurements and ABI determination
The measurements in the study group began after a ten-
minute rest period. Each observer was assigned an aide,
who was responsible for guiding the observer to the num-
bered beds in the correct time sequence, as set out in a pre-
determined list, and for recording the readings on a
standard form. The aide ensured the correct sequence of
measurements and the blinding of the observer to his/her
previous measurements on the same subject. The observ-
ers had no access to the measures. Additionally, control-
lers verified the accuracy of the measurement sequence
and procedure at each bed.
Over the course of about 90 minutes, each subject saw
three observers, one from each of the occupational
groups. Each observer was given a list of six subjects to
measure, and always completed all six subjects on the list
before returning (approximately 45 minutes later) to the
first person on the list to repeat the measurements on the
same subjects in the same sequence. The volunteers
remained supine between observers, resulting in a resting
period of 5–10 minutes between each set of readings (by
different observers).
The Doppler ultrasound device with which the ABI read-
ings were taken was the same one used in the getABI study
[8,12] (Kranzbühler 8 MHz, Solingen, Germany). Meas-
urements were performed on subjects resting in a supine
position with the upper body as flat as possible, since
readings taken in the sitting or semi-sitting position may
result in a substantial increase in the tibial artery blood
pressure. After the initial ten-minute rest, each observer
used a blood pressure cuff and a Doppler device to take
bilateral readings of systolic blood pressure (SBP) at the
anterior and posterior tibial arteries and the brachial
artery (in that order). Once the manometer pressure was
released, the first pulse sound audible through the Dop-BMC Cardiovascular Disorders 2006, 6:33 http://www.biomedcentral.com/1471-2261/6/33
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pler device as the cuff was deflated marked the systolic
arterial blood pressure. To eliminate possible noise inter-
ference from activity at neighboring beds, headphones
were used.
The ratio of ankle SBP to arm SBP yields the ABI value.
Calculations were performed according to the recommen-
dations of the American Heart Association [1]. Ankle pres-
sure on either side was the higher of the pressure at either
the anterior or posterior tibial arteries on that side. Arm
pressure was either the average of the two arm pressure
readings, if the difference between the two arms was <10
mmHg, or the higher of the two, if the difference between
the two sides was ≥ 10 mmHg. The ABI value for left and
right sides was calculated as the left or right ankle pressure
divided by the arm pressure. The lower of the two ABI val-
ues (right or left) was the subject's overall ABI [13]. Note
that on the study day only raw values were recorded. The
ABIs were calculated later by the statisticians. All data were
double-entered into the data base to ensure accuracy of
data entry.
Sample size
In a previous study [14] the difference between the stand-
ard deviations of the most and least experienced observers
was found to be 0.05 ABI points (standard deviations of
0.073 and 0.120 respectively). We decided that our study
should at least be able to detect a two-way difference
between the standard deviations of two observers of half
the above value (0.025 ABI points). Given a sample size
Table 1: Demographic data for the 192 subjects who reported on day of study
Group 1 Group 2 Group 3 Group 4 Group 5 
Stand-bys
Total p-values 
(global test 
of all 5 
groups)*
Validation 
groups 
(Groups 1, 2 
and 3)
Number of participants 36 36 36 36 48 192 108
Age: mean (± SD) 68.8 (1.4) 68.7 (1.5) 68.5 (1.5) 68.3 (1.5) 68.7 (2.4) 68.6 (1.7) 0.619 68.7 (1.5)
Sex: N (%) 0.530
M 15 (41.7%) 20 (55.6%) 15 (41.7%) 19 (52.8%) 27 (56.3%) 96 (50%) 50 (46.3%)
F 21 (58.3%) 16 (44.4%) 21 (58.3%) 17 (47.2%) 21 (43.7%) 96 (50%) 58 (53.7%)
BMI: mean (± SD) 28.5 (4.3) 29.2 (4.7) 29.2 (4.0) 29.0 (5.2) 29.3 (4.9) 29.1 (4.6) 0.956 29.0 (4.3)
< 25: N (%) 5 (13.9%) 7 (19.4%) 2 (5.6%) 5 (13.9%) 11 (22.9%) 30 (15.6%) 0.455 14 (13.0%)
25 – < 30: N (%) 19 (52.8%) 16 (44.4%) 19 (52.8%) 18 (50.0%) 16 (33.3%) 88 (45.8%) 54 (50.0%)
>= 30: N (%) 12 (33.3%) 13 (36.1%) 15 (41.7%) 13 (36.1%) 21 (43.8%) 74 (38.5%) 40 (37.0%)
WHR: mean (± SD) 0.91 (0.09) 0.93 (0.09) 0.91 (0.08) 0.95 (0.09) 0.92 (0.08) 0.92 (0.09) 0.408 0.92 (0.09)
M 0.97 (0.05) 1.0 (0.04) 0.99 (0.07) 1.0 (0.06) 0.97 (0.07) 0.99 (0.05)
F 0.86 (0.09) 0.84 (0.05) 0.86 (0.05) 0.89 (0.07) 0.87 (0.05) 0.86 (0.06)
Smoker status: N (%)
Active smoker 3 (8.3%) 3 (8.3%) 4 (11.1%) 7 (19.4%) 6 (12.5%) 23 (12.0%) 0.538 10 (9.3%)
Former smoker 17 (47.2%) 17 (47.2%) 10 (27.8%) 11 (30.6%) 19 (39.6%) 74 (38.5%) 44.(40.7%)
Non-smoker 16 (44.4%) 16 (44.4%) 22 (61.1%) 18 (50.0%) 23 (47.9%) 95 (49.5%) 54 (50.0%)
Hypertension: N (%)
Yes 20 (57.1%) 20 (57.1%) 21 (60.0%) 20 (55.6%) 34 (70.8%) 115 (60.8%) 0.571 61 (58.1%)
No 15 (42.9%) 15 (42.9%) 14 (40.0%) 16 (44.4%) 14 (29.2%) 74 (39.2%) 44 (41.9%)
Missing 1110 0 3 3
Hypercholesterolemia: N 
(%)
Yes 18 (52.9%) 16 (45.7%) 23 (65.7%) 16 (55.2%) 21 (48.8%) 94 (53.4%) 0.501 57 (54.8%)
No 16 (47.1%) 19 (54.3%) 12 (34.3%) 13 (44.8%) 22 (51.2%) 82 (46.6%) 47 (45.2%)
Missing 2117 5 1 6 4
Diabetes: N (%)
Yes 4 (11.1%) 7 (19.4%) 6 (16.7%) 5 (13.9%) 11 (22.9%) 33 (17.2%) 0.673 17 (15.7%)
No 32 (88.9%) 29 (80.6%) 30 (83.3%) 31 (86.1%) 37 (77.1%) 159 (82.8%) 91 (84.3%)
Vascular-widening 
procedures (n): N (%)
Yes 0 (0%) 1 (2.8%) 0 (0%) 2 (5.6%) 3 (6.5%) 6 (3.2%) 0.359 1 (0.9%)
No 36 (100%) 35 (97.2%) 36 (100%) 34 (94.4%) 43 (93.5%) 184 (96.8%) 107 (99.1%)
Missing 0000 2 2 0
* p-values: Chi square, Fisher's exact test or analysis of varianceBMC Cardiovascular Disorders 2006, 6:33 http://www.biomedcentral.com/1471-2261/6/33
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of 108 (three runs of the design), the power for this com-
parison in an F-test was calculated as 93%, which is
acceptable.
Statistical analysis
For all statistical tests, two-sided p values <0.05 were con-
sidered statistically significant. Characteristics of the ABI
study subjects were analyzed using Chi-square or Fisher's
exact test for contingency tables, and t-test or one-way
ANOVA for the comparison of two or more means.
Each of the ABI values was assumed to represent the sum
of the true mean ABI value and random variation from
several sources. Analysis of ABI variability was done using
a mixed model (Proc Mixed SAS™ Statistical Software
Release 9.1.3) with two random factors and their interac-
tion, the subjects (108 levels) and the observers (18 lev-
els). Note that the inclusion of the patient as a factor
makes it possible to account for and calculate intra-
patient correlation. No repeated measures model was
used.
The mean variation of the ABI measures in the case of
multiple measurements can be broken down into the fol-
lowing four variance components:
a. Variance of the true ABI values based on mean ABI
between different subjects, i.e. variance of the ABI that is
medically interpreted.
b. Variance of ABI measurements when multiple measure-
ments are performed on the same subject by the same
observer – the so-called intraobserver variance, assumed
to be due to measurement error and physiological varia-
tion.
c. Variance in ABI measurements when multiple measure-
ments are performed on the same subject by different
observers (first component of interobserver variance),
due to a systematic measurement bias in the individual
observer, e.g. an observer generally measuring higher or
lower values than others (independent of the specific sub-
ject).
d. An additional variance of ABI measurements when
multiple measurements are performed on the same sub-
ject by different observers, caused by interaction between
subject and observer (second component of interob-
server variance), i.e. an observer measuring higher or
lower values than others for specific subjects only. For exam-
ple, some observers may have a harder time measuring
obese subjects than do other observers.
By adding the three variance components of multiple
measurements on the same subject, namely the intraob-
server variance b and the two interobserver variance
components c and d, one obtains the total variance for
multiple measurements on the same subject by different
observers:
Total variance of all ABI values for a single subject = b + c
+ d
Simple addition is permissible when the individual vari-
ance components are independent of one another. The
standard deviation of the ABI measurements for a single
subject is the root of the total variance.
In order to evaluate the overall quality of the ABI as a
measurement technique for discrimination between dif-
ferent subjects, all four variance components must be con-
sidered. An intraclass correlation coefficient (ICC) is
normally formed for this purpose. The ICC indicates the
proportion (in percent) of the total variance in measure-
ment results between subjects that can be explained by the
"biological" or real variance between the subjects exam-
ined. A high ICC indicates that the measurements can be
used to discriminate between individuals. ICC values ≥
0.75 are said to be acceptable [15]. The ICC can also be
understood as a generalization of the coefficient of deter-
mination, or the square of the correlation coefficient in
the case of only two sources of variations (two variables).
Table 2: Combination schedule of observers and patients
Gp1 Gp2 Gp3 Gp4 Gp5 Gp6
AN1 Pat01 – MA1 Pat02 – MA2 Pat03 – MA3 Pat04 – MA4 Pat05 – MA5 Pat06 – MA6
An2 Pat07 – MA2 Pat08 – MA3 Pat09 – MA4 Pat10 – MA5 Pat11 – MA6 Pat12 – MA1
An3 Pat13 – MA3 Pat14 – MA4 Pat15 – MA5 Pat16 – MA6 Pat17 – MA1 Pat18 – MA2
An4 Pat19 – MA4 Pat20 – MA5 Pat21 – MA6 Pat22 – MA1 Pat23 – MA2 Pat24 – MA3
An5 Pat25 – MA5 Pat26 – MA6 Pat27 – MA1 Pat28 – MA2 Pat29 – MA3 Pat30 – MA4
An6 Pat31 – MA6 Pat32 – MA1 Pat33 – MA2 Pat34 – MA3 Pat35 – MA4 Pat36 – MA5
AN: Angiologist; GP: General Practitioner; MA: Medical Assistant
Example: Patient 20 (Pat20) is measured by Angiologist 4 (AN4), General Physician 2 (GP2) and Medical Assistant 5 (MA5). Each subject saw exactly 
one observer from each of the three observer groups, and each observer measured six subjects. Note that this schedule was repeated twice on 
each patient group of 36 patients to obtain repeat measurements.BMC Cardiovascular Disorders 2006, 6:33 http://www.biomedcentral.com/1471-2261/6/33
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Therefore, the interpretation of the ICC is the same as for
the coefficient of determination, namely the proportion
of total variance that is explainable by the real variance
between subjects.
The intraobserver variability of each individual observer
can also be determined. By taking the mean of these val-
ues for all observers within one occupational group (angi-
ologists, general physicians and medical office assistants)
it is possible to assess the average quality of the measure-
ments by each of the three groups.
Bland-Altman plots were used to visualize measurement
errors. For each subject, the differences between the first
and second measurements were plotted against the mean
of the two measures with 95% limits of agreement [16].
All data analyses were performed using SAS™ Statistical
Software (Release 9.1.3, SAS Institute Inc., Cary, NC,
USA).
Results
Subject characteristics
Of the 200 subjects invited to participate, 192 (96%)
appeared on the study day. The data for the pilot study
(rehearsal) were not analyzed. Demographic data for all
subjects who appeared on the study day are shown in
Table 1, subdivided into Groups 1–4 for duplicate ABI
determination and a fifth group of stand-bys. The subjects
in the five groups were equal for all recorded basic data,
including PAD risk factors.
The 108 individuals (53.7% female) for whom complete
duplicate measurements were obtained had a mean age of
68.7 (1.5) years, mean BMI of 29.0 (4.3) kg/m2, and mean
waist-hip ratio of 0.92 (0.09). Active smokers made up
9.3% of the sample and former smokers 40.7%; 58.1%
were hypertensive, 54.8% dyslipidemic, and 15.7% dia-
betic. Only one subject (0.9%) of Groups 1–3 reported
having had peripheral vascular-widening measures in the
past. In Groups 4 and 5 five subjects (5.9%) reported hav-
ing had such measures.
ABI measurements
ABI measurements were performed on 189 of the 192
subjects who enrolled in the study. One subject dropped
out after the basic examination, before any ABI determi-
nations were performed, and on two other subjects no ABI
measures could be obtained for technical reasons (very
obese subjects with upper arm too large for the blood
pressure cuff).
In Groups 1–3 (108 subjects), the ABI measurement pro-
gram was completed as planned with full sets of duplicate
measurements. Because of time restrictions, full sets of
measurements were not obtained from all subjects in the
fourth group. The analysis was based on the first three
groups of subjects (58 women, 50 men) for whom com-
plete measurements were obtained.
The results of the ABI measurements are shown in Table 3.
Overall 15 (7.9%) subjects had ABI measures <0.90 and
would therefore be classified as possibly having PAD. An
ABI >1.4, i.e. a ratio that is associated with arterial calcifi-
cation and increased stiffening of the arterial walls, was
not determined in any of the 189 subjects.
There are no significant differences in mean brachial SBP
or mean ABI between Groups 1–3 and incomplete Group
4 (Table 4). The mean SBP in Group 5 is not comparable
with the mean SBP in the other four groups, because for
the stand-by subjects a ten-minute rest period was not
scheduled before the single ABI measurement.
ICC
a
abcd
=
+++
Table 3: Results of duplicate (Groups 1–4) and single (Group 5) ABI measurements
Gr1 Gr2 Gr3 Gr4 Gr5 Total p-value Gr1-Gr3
ABI
- N 36 36 36 36 45 189 108
- Mean 1.10 1.08 1.11 1.06 1.04 1.08 0.055 1.10
- SD 0.09 0.11 0.10 0.13 0.17 0.13 0.10
- Min 0.94 0.74 0.92 0.6 0.52 0.52 0.74
- Max 1.35 1.32 1.37 1.24 1.27 1.37 1.37
- Missing 000000 0
ABI
< 0.90 0 (0%) 2 (5.6%) 0 (0%) 5 (13.9%) 8 (17.8%) 15 (7.9%) 0.003 2 (1.9%)
>= 0.90 36 (100%) 34 (94.4%) 36 (100%) 31 (86.1%) 37 (82.2%) 174 (92.1%) 106 (98.2%)
Missing 000000 0
p-values: Fisher's exact test, analysis of varianceBMC Cardiovascular Disorders 2006, 6:33 http://www.biomedcentral.com/1471-2261/6/33
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Bland-Altman plots
The simplest and most direct measure of agreement
between two measured values is the difference between
them. This is true not only when seeking to determine
agreement between measures obtained by two different
measurement methods, but also when seeking to deter-
mine the reproducibility of a measure, in this case an ABI
measure, when repeat measurements are performed by
the same observer on the same subject.
Bland-Altman plots were created to visualize the ABI
measurement error [16]. The difference between two ABI
values was plotted against the mean of the same two val-
ues, in order to show whether systematic differences exist
between the repeat measurements as a function of abso-
lute value (mean) of the ABI. The two blue lines represent
two standard deviations of the differences, in other words
the upper limit of the difference between two measures up
to which about 95% of all the differences between meas-
ures can be found. These are the limits of agreement
(mean difference ± 2SD) as described by Bland and Alt-
man.
Figure 2 illustrates the differences between the duplicate
ABI measures by a single angiologist (the reproducibility
of this observer) for all of his measures (18 subjects, six
per group). An analogous plot could be shown for each
observer. Figure 3 combines these six plots for all six angi-
ologists in one figure, showing the differences between
duplicate ABI measurements obtained by all six angiol-
ogists on all 108 subjects in Groups 1–3. Note that each
angiologist measured 18 different subjects (6 angiologists
* 18 subjects = 108 subjects). Figure 4 combines the dif-
ferences between duplicate measures on all 108 subjects
by all 18 observers (six angiologists, 6 GPs and six MAs).
Note that now the plot contains 3*108 points because
one subject is measured by three different observers
(duplicate measurements by one angiologist, one GP, and
one MA). The plotted points in Figure 5 show the differ-
ences between all 108 first measurements by 6 angiol-
ogists and 108 first measurements by 6 GPs. The mean
difference indicates the bias between the two first meas-
urements.
Discussion
Previously only a few small studies (6–36 subjects) existed
on the inter- and intraobserver variability of ABI measures
[14,17-19]. These studies worked with small numbers of
observers and with patients who had symptomatic PAD or
reduced ABIs (<0.95). By contrast, our study focused on a
large number of elderly unselected individuals, who are
the most likely to be subjects of screening measures, as in
primary care. With a total of 18 observers of different tech-
nical backgrounds and levels of experience, the study also
reflects the everyday conditions of primary care.
From the fact that the mean differences between the ABI
measurements in Figure 3 and Figure 5 are very close to 0,
the following two conclusions can be drawn: Neither the
time difference of about 45 minutes between the two
measures on the same subject (repeat measurements by
angiologists, GPs or MAs) nor differences in observer cat-
egory (e.g. angiologists versus GPs) resulted in a system-
atic bias in the measures. Furthermore, comparison
between the two groups of physicians (Figure 5) leads to
the conclusion that the ABI measures taken by the GPs are
just as accurate as those taken by the angiologists. In sum,
Bland-Altman plots show that there are only small differ-
ences and no systematic bias between the observers from
three occupational groups with different training back-
grounds. This confirms the appropriateness of ABI meas-
urements for screening for PAD and generalised
atherosclerosis in the GP setting.
Previous studies indicate both that the variability in ABI
measures is highly dependent on the experience of the
observers, and that the value of the ABI measures depends
on the apparatus with which the measurements are per-
formed [14,17-19]. However, the strength of these studies'
conclusions must be considered questionable, as all stud-
Table 4: Comparison of mean systolic arm pressure between subjects in stand-by group 5, duplicate measurement groups 1–3, and 
incomplete group 4
Brachial SBP Group 1–3 Group 4 Group 5 Total p-value
N 108 36 45 189
Mean 148 148 159 150 0.004
SD 17.0 18.1 26.8 20.4
Median 1 4 71 4 51 5 81 4 8
25th percentile 1 3 31 3 61 3 81 3 4
75th percentile 1 5 81 5 51 7 81 6 1
Min 1 1 21 1 31 1 01 1 0
Max 1 9 31 9 92 1 52 1 5
Missing 0000
p-values: analysis of varianceBMC Cardiovascular Disorders 2006, 6:33 http://www.biomedcentral.com/1471-2261/6/33
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ies had one or more major methodological limitations
such as relatively small samples of observers or patients,
or the selection of patients with symptomatic PAD. The
latter is of importance, as variability has been reported to
differ at least slightly between diseased and normal sub-
jects [17,20].
The variability in ABI measures is of particular importance
for patients moving from one observer to another, for
example as the result of changing family doctors (interob-
server variance). Moreover, the ABI should always be an
average of several measurements. Under ideal measure-
ment conditions, an ABI <0.9 is considered a readily
obtained indicator for the possible presence of PAD
[21,22]. The most recent studies nevertheless recommend
that patients with ABIs between 0.9 and 1.1 be treated as
"borderline PAD", since a 25% higher mortality is found
in this group compared to patients with ABIs of between
1.1 and 1.4 [23]. A significant increase in mortality was
also recently observed in patients with ABIs >1.4 [24].
Similar results were published by Resnick et al. in 2004;
however, because the study population consisted of abo-
riginal Americans only, the data could not necessarily be
applied to the general population [25].
Bland-Altman plot of all duplicate measurements by all six  angiologists (blue), six general physicians (red) and six medi- cal office assistants (green) on a total of 108 subjects in  groups 1–3 Figure 4
Bland-Altman plot of all duplicate measurements by 
all six angiologists (blue), six general physicians (red) 
and six medical office assistants (green) on a total of 
108 subjects in groups 1–3. Figure legend: red, green and 
blue circles = subjects; coloured lines = ± 2SD; black line = 
global mean of differences; for comparison, the difference 
between a healthy patient (ABI > 1.1) and a suspected PAD 
patient (ABI < 0.9) is 0.2 ABI points.
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Bland-Altman plot of all duplicate measurements by one angi- ologist (Number 4) on a total of 18 subjects in groups 1–3 Figure 2
Bland-Altman plot of all duplicate measurements by 
one angiologist (Number 4) on a total of 18 subjects 
in groups 1–3. Figure legend: red circles = subjects, black 
line = mean difference, blue lines = ± 2SD; for comparison, 
the difference between a healthy patient (ABI > 1.1) and a 
suspected PAD patient (ABI < 0.9) is 0.2 ABI points.
Bland-Altman plot of all duplicate measurements by all six  angiologists on a total of 108 subjects in groups 1–3 Figure 3
Bland-Altman plot of all duplicate measurements by 
all six angiologists on a total of 108 subjects in groups 
1–3. Figure legend: red circles = subjects, black line = mean 
difference, blue lines = ± 2SD; for comparison, the difference 
between a healthy patient (ABI > 1.1) and a suspected PAD 
patient (ABI < 0.9) is 0.2 ABI points.BMC Cardiovascular Disorders 2006, 6:33 http://www.biomedcentral.com/1471-2261/6/33
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Conclusion
With the partially balanced incomplete block design, it
was possible to test every possible observer combination
exactly once while performing only 16.7% of all the repeat
ABI measurements that would theoretically be required.
Thus we established the conditions for assessing compo-
nents of variance with large numbers of subjects and
observers, which can be applied also to measures other
than ABI.
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